Deutsche Bank’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-7,105
| Closed | -$21K | – | 4690 |
|
|
2016
Q3 | $21K | Sell |
7,105
-40,199
| -85% | -$119K | ﹤0.01% | 4176 |
|
|
2016
Q2 | $70K | Sell |
47,304
-86,514
| -65% | -$128K | ﹤0.01% | 4054 |
|
|
2016
Q1 | $494K | Buy |
133,818
+115,653
| +637% | +$427K | ﹤0.01% | 3171 |
|
|
2015
Q4 | $182K | Sell |
18,165
-103,998
| -85% | -$1.04M | ﹤0.01% | 3614 |
|
|
2015
Q3 | $1.66M | Buy |
122,163
+44,823
| +58% | +$609K | ﹤0.01% | 2581 |
|
|
2015
Q2 | $1.47M | Buy |
77,340
+61,384
| +385% | +$1.16M | ﹤0.01% | 2673 |
|
|
2015
Q1 | $415K | Sell |
15,956
-16,832
| -51% | -$438K | ﹤0.01% | 3309 |
|
|
2014
Q4 | $685K | Sell |
32,788
-7,408
| -18% | -$155K | ﹤0.01% | 3379 |
|
|
2014
Q3 | $1.34M | Sell |
40,196
-59,945
| -60% | -$2M | ﹤0.01% | 2775 |
|
|
2014
Q2 | $3.21M | Sell |
100,141
-396,049
| -80% | -$12.7M | ﹤0.01% | 2120 |
|
|
2014
Q1 | $22.9M | Sell |
496,190
-9,265
| -2% | -$428K | 0.02% | 851 |
|
|
2013
Q4 | $35.9M | Sell |
505,455
-90,629
| -15% | -$6.43M | 0.03% | 628 |
|
|
2013
Q3 | $51.1M | Buy |
596,084
+313,454
| +111% | +$26.9M | 0.04% | 491 |
|
|
2013
Q2 | $17.9M | Buy |
+282,630
| New | +$17.9M | 0.01% | 924 |
|